牛牛AI助理已提取核心訊息
Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed a Schedule 13G with the Securities and Exchange Commission on February 14, 2024, indicating a significant stake in bluebird bio, Inc. As of December 31, 2023, Granahan Investment Management reported beneficial ownership of 8,077,697 shares of bluebird bio's common stock, representing 7.38% of the company's class. The filing, made under Rule 13d-1(b), shows that Granahan has sole voting power over 6,741,868 shares and sole dispositive power over all 8,077,697 shares. The investment firm has declared that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio.
Granahan Investment Management LLC, an investment adviser based in Massachusetts, has filed a Schedule 13G with the Securities and Exchange Commission on February 14, 2024, indicating a significant stake in bluebird bio, Inc. As of December 31, 2023, Granahan Investment Management reported beneficial ownership of 8,077,697 shares of bluebird bio's common stock, representing 7.38% of the company's class. The filing, made under Rule 13d-1(b), shows that Granahan has sole voting power over 6,741,868 shares and sole dispositive power over all 8,077,697 shares. The investment firm has declared that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of bluebird bio.
總部位於馬薩諸塞州的投資顧問格拉納漢投資管理有限責任公司已於2024年2月14日向美國證券交易委員會提交了附表13G，表明藍鳥生物公司擁有大量股份。截至2023年12月31日，格拉納漢投資管理公司報告了藍鳥生物普通股8,077,697股的實益所有權，佔該公司類別的7.38％。該文件是根據第13d-1（b）條提交的，顯示格拉納漢對6,741,868股股票擁有唯一的投票權，對所有8,077,697股股票擁有唯一的處置權。該投資公司宣佈，這些股票是在正常業務過程中收購的，不是爲了改變或影響藍鳥生物的控制權。
總部位於馬薩諸塞州的投資顧問格拉納漢投資管理有限責任公司已於2024年2月14日向美國證券交易委員會提交了附表13G，表明藍鳥生物公司擁有大量股份。截至2023年12月31日，格拉納漢投資管理公司報告了藍鳥生物普通股8,077,697股的實益所有權，佔該公司類別的7.38％。該文件是根據第13d-1（b）條提交的，顯示格拉納漢對6,741,868股股票擁有唯一的投票權，對所有8,077,697股股票擁有唯一的處置權。該投資公司宣佈，這些股票是在正常業務過程中收購的，不是爲了改變或影響藍鳥生物的控制權。
有用
沒用